Medclair AB (NGM:MCLR)

Market Cap	237.58M +93.3%
Revenue (ttm)	50.04M -0.5%
Net Income	5.22M +114.5%
EPS	0.07 +165.3%
Shares Out	82.49M
PE Ratio	42.58
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	61,986
Average Volume	76,488
Open	n/a
Previous Close	2.850
Day's Range	n/a
52-Week Range	1.395 - 3.350
Beta	0.98
RSI	54.59
Earnings Date	Feb 20, 2026

About Medclair AB

Medclair AB, a research and development company, specializes in the measurement, collection, and destruction of nitrous oxide (N2O). It offers mobile destruction unit, a solution that can be moved anywhere, where N2O is needed for pain relief; central destruction unit, a system designed for larger N2O destruction volumes; Recycling Decomposition Unit a, intelligent solution that effectively collects Nitrous Oxide (N2O) from discarded N2O bottles and decomposes it within a self-supporting system; and Nitrous Oxide Detector, an N2O measuring devi...

• Industry: Crude Petroleum and Natural Gas
• Founded: 2005
• Employees: 14
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: MCLR

Financial Performance

In 2024, Medclair AB's revenue was 35.95 million, a decrease of -15.25% compared to the previous year's 42.42 million. Losses were -664,000, -76.16% less than in 2023.